Alpha Layer / Signal Explorer

Signal Explorer

10-K · 10-Q · 8-K · last 6 months · ← back to feed

Clear ×
Invivyd, Inc. IVVD

Showing 10-K, 10-Q & 8-K from the last 6 months. Need full history or all form types?

Apr 9, 2026 8-K 12 signals fired
Other
Ceo Team Pride Statement Kol Endorsement Safety Differentiated Interim Data Positive Fda Aligned Enrollment Ahead Of Schedule Fast Track Designation Received
Core
Clinical Trial Result Indication Expansion Clinical Hold Combination Therapy Mentioned Lead Asset Progress
Mar 5, 2026 10-K 88 signals fired · top 15
Other
Cybersecurity Breach Reputational Harm Disclosure Net Loss Reported Ipo Net Proceeds Disclosure Cash Flow Statement Investing Activities Share Repurchase Activity Disclosed Segment Aggregation Disclosure Patent Family Portfolio Disclosure Deferred Tax Asset Valuation Disclosure Nol Carryforward Expiration Disclosure Headcount Disclosure Standard Competition Disclosure Rsu Psu Vesting Schedule Disclosed Termination For Material Breach Clause Nyse Listing Disclosure
Core
Regulatory Designation Only
Mar 5, 2026 8-K 6 signals fired
Core
Clinical Trial Result Combination Therapy Mentioned Indication Expansion Lead Asset Progress
Other
Kol Endorsement Patient Retention High
Jan 8, 2026 8-K 11 signals fired
Other
Auditor Appointment Ratification Board Committee Member Listing Checkpoint Inhibitor Program Covid19 Pandemic Uncertainty Disclosure Publication Positive Interim Data Positive Patient Retention High
Core
Clinical Trial Result Lead Asset Progress Indication Expansion Clinical Hold
Dec 23, 2025 8-K 9 signals fired
Core
Regulatory Designation Only Clinical Hold Clinical Trial Result
Other
Fast Track Designation Received Fast Track Granted Fda Aligned Orphan Status Granted
Biotech Risk
Orphan Drug Designation
Biotech v3
Ind Submission Planned
Nov 24, 2025 8-K 6 signals fired
Biotech v3
Ind Submission Planned
Other
Kol Endorsement Safety Differentiated Interim Data Positive
Core
Combination Therapy Mentioned Lead Asset Progress
Nov 19, 2025 8-K 9 signals fired
Other
Ipo Net Proceeds Disclosure Fcpa Compliance Representation Corporate Organization And Standing Representation Sanctions Compliance Representation Hipaa Fraud Abuse Laws Disclosure Auditor Appointment Ratification Ipo Or Capital Raising Completion Institutional Investment Form S3 Shelf Registration Disclosure
Nov 6, 2025 10-Q 35 signals fired · top 15
Other
Rsu Psu Vesting Schedule Disclosed Net Loss Reported Nasdaq Minimum Bid Price Delisting Notice Cash Flow Statement Investing Activities Ipo Net Proceeds Disclosure Financing Activities Cash Flow Disclosure Form S3 Shelf Registration Disclosure Fair Value Hierarchy Disclosure Other Income Expense Disclosure Operating Lease Rent Expense Disclosed Stock Option Intrinsic Value Disclosure Ipo Or Capital Raising Completion Termination For Material Breach Clause Equity Award Plan Types Enumerated Personnel Cost Decrease Disclosure
Nov 6, 2025 8-K 5 signals fired
Core
Clinical Trial Result Indication Expansion Combination Therapy Mentioned
Other
Checkpoint Inhibitor Program Patient Retention High
Oct 30, 2025 8-K 10 signals fired
Core
Clinical Trial Result Combination Therapy Mentioned Clinical Hold
Other
Forward Looking Statement Definition Patient Retention High Covid19 Pandemic Uncertainty Disclosure Ip Protection Methods Disclosed Interim Data Positive Fda Aligned Publication Positive